X-15526092-A-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_203281.3(BMX):​c.881A>T​(p.Tyr294Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000101 in 1,089,793 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 23)
Exomes 𝑓: 0.000010 ( 0 hom. 4 hem. )

Consequence

BMX
NM_203281.3 missense

Scores

2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.51
Variant links:
Genes affected
BMX (HGNC:1079): (BMX non-receptor tyrosine kinase) This gene encodes a non-receptor tyrosine kinase belonging to the Tec kinase family. The protein contains a PH-like domain, which mediates membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3), and a SH2 domain that binds to tyrosine-phosphorylated proteins and functions in signal transduction. The protein is implicated in several signal transduction pathways including the Stat pathway, and regulates differentiation and tumorigenicity of several types of cancer cells. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016]
ACE2 (HGNC:13557): (angiotensin converting enzyme 2) The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. ACE2 is known to be expressed in various human organs, and its organ- and cell-specific expression suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2, the latter is the causative agent of coronavirus disease-2019 (COVID-19). Multiple splice variants have been found for this gene and the dACE2 (or MIRb-ACE2) splice variant has been found to be interferon inducible. [provided by RefSeq, Nov 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17385978).
BS2
High Hemizygotes in GnomAdExome4 at 4 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BMXNM_203281.3 linkc.881A>T p.Tyr294Phe missense_variant Exon 9 of 19 ENST00000348343.11 NP_975010.1 P51813

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BMXENST00000348343.11 linkc.881A>T p.Tyr294Phe missense_variant Exon 9 of 19 1 NM_203281.3 ENSP00000308774.6 P51813

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
AF:
0.0000101
AC:
11
AN:
1089793
Hom.:
0
Cov.:
27
AF XY:
0.0000112
AC XY:
4
AN XY:
355585
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26217
American (AMR)
AF:
0.00
AC:
0
AN:
34938
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19276
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30094
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53163
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40443
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4107
European-Non Finnish (NFE)
AF:
0.0000132
AC:
11
AN:
835748
Other (OTH)
AF:
0.00
AC:
0
AN:
45807
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
23
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 12, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.881A>T (p.Y294F) alteration is located in exon 9 (coding exon 8) of the BMX gene. This alteration results from a A to T substitution at nucleotide position 881, causing the tyrosine (Y) at amino acid position 294 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.29
T;T;T
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.73
.;.;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.17
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N;N;N
PhyloP100
4.5
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.5
N;N;N
REVEL
Benign
0.057
Sift
Benign
0.19
T;T;T
Sift4G
Benign
0.32
T;T;T
Polyphen
0.34
B;B;B
Vest4
0.32
MutPred
0.34
Loss of phosphorylation at Y294 (P = 0.0196);Loss of phosphorylation at Y294 (P = 0.0196);Loss of phosphorylation at Y294 (P = 0.0196);
MVP
0.67
MPC
0.35
ClinPred
0.40
T
GERP RS
5.5
Varity_R
0.26
gMVP
0.53
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1924710205; hg19: chrX-15544215; API